Olema Pharmaceuticals, Inc.
| CIK |
Ticker |
Name |
Accession Number |
Date |
Form |
| 1750284 |
|
Olema Pharmaceuticals, Inc. |
0000950170-25-059348 |
2025-04-28 16:30:15 |
DEF 14A
|
| 1750284 |
|
Olema Pharmaceuticals, Inc. |
0001193125-24-275608 |
2024-12-11 16:30:15 |
SC 13G
|
| 1750284 |
|
Olema Pharmaceuticals, Inc. |
0000902664-24-004309 |
2024-06-14 16:34:22 |
SC 13G
|
| 1750284 |
|
Olema Pharmaceuticals, Inc. |
0001172661-24-001695 |
2024-03-22 16:31:29 |
SC 13G
|
| 1750284 |
|
Olema Pharmaceuticals, Inc. |
0001086364-24-005534 |
2024-01-29 17:25:50 |
SC 13G
|
| 1750284 |
|
Olema Pharmaceuticals, Inc. |
0001558370-23-007258 |
2023-04-28 16:05:10 |
DEF 14A
|
| 1750284 |
|
Olema Pharmaceuticals, Inc. |
0001104659-23-043619 |
2023-04-10 16:33:47 |
SC 13G
|
| 1750284 |
|
Olema Pharmaceuticals, Inc. |
0001085146-23-001011 |
2023-02-10 13:18:38 |
SC 13G
|
| 1750284 |
|
Olema Pharmaceuticals, Inc. |
0000834237-22-010318 |
2022-07-08 16:57:08 |
SC 13G
|
| 1750284 |
|
Olema Pharmaceuticals, Inc. |
0001558370-22-006304 |
2022-04-28 16:25:28 |
DEF 14A
|
| 1750284 |
|
Olema Pharmaceuticals, Inc. |
0001104659-22-020253 |
2022-02-11 13:26:40 |
SC 13G
|
| 1750284 |
|
Olema Pharmaceuticals, Inc. |
0001104659-22-018233 |
2022-02-10 08:28:05 |
SC 13G
|
| 1750284 |
|
Olema Pharmaceuticals, Inc. |
0000834237-22-007212 |
2022-02-04 16:12:12 |
SC 13G
|
| 1750284 |
|
Olema Pharmaceuticals, Inc. |
0001558370-21-004911 |
2021-04-27 16:06:35 |
DEF 14A
|
| 1750284 |
|
Olema Pharmaceuticals, Inc. |
0001104659-21-024232 |
2021-02-16 16:39:35 |
SC 13G
|
| 1750284 |
|
Olema Pharmaceuticals, Inc. |
0001274173-21-000087 |
2021-02-12 15:42:43 |
SC 13G
|
| 1750284 |
|
Olema Pharmaceuticals, Inc. |
0000902219-21-000145 |
2021-02-04 09:51:50 |
SC 13G
|
| 1750284 |
|
Olema Pharmaceuticals, Inc. |
0000935836-20-000676 |
2020-12-03 16:06:40 |
SC 13D
|
| 1750284 |
|
Olema Pharmaceuticals, Inc. |
0000929638-20-001105 |
2020-11-23 16:59:17 |
SC 13G
|
| 1750284 |
|
Olema Pharmaceuticals, Inc. |
0000921895-20-003063 |
2020-11-20 17:23:15 |
SC 13D
|
